Rebecca Brachman: A new class of drug that could prevent depression and PTSD
Rebecca Brachman: Uma nova classe de medicamentos que pode prevenir a depressão e o estresse pós-traumático
Rebecca Brachman is a pioneer in the field of preventative psychopharmacology, developing drugs to enhance stress resilience and prevent mental illness. Full bio
Double-click the English transcript below to play the video.
were made from, of all things,
foram feitos, dentre todas as coisas,
que sobraram da Segunda Guerra Mundial.
one in five soldiers develop depression,
cinco soldados desenvolve depressão,
pós-traumático, ou ambos.
that are at high risk for these diseases.
alto risco de desenvolver essas doenças.
cancer patients, aid workers, refugees --
trabalhadores humanitários, refugiados,
or major life stress.
ou a grande estresse na vida.
these disorders are,
distúrbios serem comuns,
if they work at all,
se funcionam de alguma forma,
discovered the first vaccine --
descobriu a primeira vacina,
a prophylactic for a disease,
uma profilaxia para uma doença,
to extend to psychiatric diseases.
se estendesse a doenças psiquiátricas.
accidentally discovered
descobrimos acidentalmente
depression and PTSD.
prevenir a depressão e o TEPT.
whether they work in humans.
se funcionam em humanos.
psychopharmaceuticals
nova de medicamentos.
stress resilience,
a resiliência ao estresse.
de potenciadores de resiliência.
that you've since recovered from.
do qual vocês se recuperaram:
you missed a flight.
ou um voo perdido.
is the active biological process
é o processo biológico ativo
to bounce back after stress.
após o estresse.
and your immune system fights it off.
do sistema imunológico contra ele.
enough stressor,
significativo o bastante
such as depression.
psiquiátrico, como depressão.
de transtorno depressivo maior
of major depressive disorder
against purely biological stressors,
de resiliência podem proteger
like bullying and isolation.
como o bullying e o isolamento.
em que demos aos camundongos
of stress hormones.
de hormônios do estresse.
without a psychological component.
sem um componente psicológico.
of antidepressant treatment beforehand,
antidepressivo de antemão,
enhancer given a week before
de resiliência, dada uma semana antes,
the depressive behavior.
o comportamento depressivo,
a drug has ever been shown
que se apresenta um medicamento
negativos do estresse.
often lifelong, clinical diseases.
crônicas e muitas vezes de toda a vida.
of substance abuse, homelessness,
de abuso de substâncias, fuga do lar,
mal de Alzheimer, suicídio.
is over three trillion dollars per year.
é superior a US$ 3 trilhões por ano.
where we know someone is predictively
sabemos que alguém tem, previsivelmente,
to extreme stress.
ao estresse extremo,
going into an earthquake zone.
indo a uma zona de terremotos.
of a resilience enhancer
de um potenciador de resiliência
by looters or worse,
por saqueadores, ou pior,
against developing depression or PTSD
o desenvolvimento de depressão ou TEPT
from experiencing the stress,
de passar pelo estresse,
her susceptibility to depression and PTSD,
sua suscetibilidade à depressão e ao TEPT,
her home, her family or even her life.
a casa, a família ou até mesmo a vida.
the smallpox vaccine,
a vacina contra a varíola,
surgiram rapidamente em seguida.
was widely available.
estivesse amplamente disponível.
sensitive and creative and empathetic.
mais sensíveis, criativas e empáticas.
by constitution and not biology.
e não pela biologia.
today about depression.
hoje sobre a depressão.
opened the door
de Jenner abriu as portas
that followed after,
open the possibility of a whole new field:
abrem a possibilidade de um novo campo:
choose to do with it.
escolhemos fazer com ela.
ABOUT THE SPEAKER
Rebecca Brachman - Neuroscientist, writer, entrepreneurRebecca Brachman is a pioneer in the field of preventative psychopharmacology, developing drugs to enhance stress resilience and prevent mental illness.
Why you should listen
Current treatments for mood disorders only suppress symptoms without addressing the underlying disease, and there are no known cures. The drugs Rebecca Brachman is developing would be the first to prevent psychiatric disorders such as post-traumatic stress disorder (PTSD) and depression.
Brachman completed her PhD at Columbia University, prior to which she was a fellow at the National Institutes of Health, where she discovered that immune cells carry a memory of psychological stress and that white blood cells can act as antidepressants and resilience-enhancers. Brachman's research has been featured in The Atlantic, WIRED and Business Insider, and her work was recently described by Dr. George Slavich on NPR as a "moonshot project that is very much needed in the mental health arena."
In addition to conducting ongoing research at Columbia, Brachman is an NYCEDC Entrepreneurship Lab Fellow and cofounder of Paravax -- a biotech startup developing vaccine-like prophylactic drugs ("paravaccines") -- along with her scientific collaborator, Christine Ann Denny. She is also working on a non-profit venture to repurpose existing generic drugs for use as prophylactics, and previously served as the Interim Program Director for Outreach at the Zuckerman Institute at Columbia University.
Brachman is also a playwright and screenwriter. She holds Bachelor's degrees in both neuroscience and creative wWriting, and she is currently working on a tech-focused writing project with her long-time writing partner, Sean Calder ("Grimm," "Damages," "ER"). She served as the director of NeuWrite, a national network of science-writing groups that fosters ongoing collaboration between scientists, writers and artists, and she has been featured as a storyteller at The Story Collider.
(Photo: Kenneth Willardt)
Rebecca Brachman | Speaker | TED.com